These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35218046)
21. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Aguerre V; Castaños C; Pena HG; Grenoville M; Murtagh P Pediatr Pulmonol; 2010 Dec; 45(12):1180-5. PubMed ID: 20717912 [TBL] [Abstract][Full Text] [Related]
22. Successful treatment of postinfectious bronchiolitis obliterans with gamma globulin in a tertiary center: 10 years of experience. Yilmaz Aİ; Gül Y; Kapaklı H; Ünal G; Çağlar HT; Ercan F; Reisli İ; Keleş S; Poyraz N; Pekcan S Pediatr Pulmonol; 2023 Oct; 58(10):2769-2776. PubMed ID: 37469295 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for bronchiolitis obliterans complicating adenovirus pneumonia in children: a meta-analysis. Yao MM; Gao TJ; Zhao M; Fu YH; Liu J; Wang TJ; Yang Y Front Pediatr; 2024; 12():1361850. PubMed ID: 39149537 [TBL] [Abstract][Full Text] [Related]
24. Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment. Zhang XM; Lu AZ; Yang HW; Qian LL; Wang LB; Zhang XB World J Pediatr; 2018 Oct; 14(5):498-503. PubMed ID: 30269305 [TBL] [Abstract][Full Text] [Related]
25. Caspase-1 and interleukin-18 in children with post infectious bronchiolitis obliterans: a case-control study. Şişmanlar Eyüboğlu T; Aslan AT; Ramaslı Gürsoy T; Pekcan S; Köse M; Hangül M; Aral LA; Bulut V Eur J Pediatr; 2022 Aug; 181(8):3093-3101. PubMed ID: 35705877 [TBL] [Abstract][Full Text] [Related]
26. Clinical profile and course of children with postinfectious bronchiolitis obliterans from a tertiary care hospital. Gulla KM; Jat KR; Lodha R; Kabra SK Lung India; 2020; 37(1):8-12. PubMed ID: 31898614 [TBL] [Abstract][Full Text] [Related]
27. Childhood bronchiolitis obliterans in Hong Kong-case series over a 20-year period. Chan KC; Yu MW; Cheung TWY; Lam DSY; Leung TNH; Tsui TK; Ip KI; Chau CSK; Lee SL; Yip AYF; Wong TW; Mak VCW; Li AM Pediatr Pulmonol; 2021 Jan; 56(1):153-161. PubMed ID: 33174693 [TBL] [Abstract][Full Text] [Related]
28. [Clinical features of severe type 7 adenovirus pneumonia: an analysis of 45 cases]. Zhang XP; Yang MY; Zhou X; Cao JS; Cai ZL; Kang XY; Xie B; Liu Y; He J; Xiao ZH Zhongguo Dang Dai Er Ke Za Zhi; 2020 May; 22(5):429-434. PubMed ID: 32434636 [TBL] [Abstract][Full Text] [Related]
29. Risk Factors for Post-infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis. Liu D; Liu J; Zhang L; Chen Y; Zhang Q Front Pediatr; 2022; 10():881908. PubMed ID: 35757133 [TBL] [Abstract][Full Text] [Related]
30. Analysis of mortality risk factors in children with severe adenovirus pneumonia: A single-center retrospective study. Xu XH; Fan HF; Shi TT; Yang DY; Huang L; Zhang DW; Lu G Pediatr Neonatol; 2023 May; 64(3):280-287. PubMed ID: 36456423 [TBL] [Abstract][Full Text] [Related]
31. Severe pneumonia caused by human adenovirus type 55 in children. Zhang D; Chen Y; Shi T; Fan H; Tian X; Zhou R; Huang L; Yang D; Lu G Front Pediatr; 2022; 10():1002052. PubMed ID: 36313878 [TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of 28 cases of bronchiolitis obliterans]. Wu XY; Luo ZX; Fu Z; Liu EM; Luo J; He L Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):845-9. PubMed ID: 24131836 [TBL] [Abstract][Full Text] [Related]
33. Risk Factors for the Development of Post-Infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis. Lee E; Park S; Kim K; Yang HJ Pathogens; 2022 Oct; 11(11):. PubMed ID: 36365019 [TBL] [Abstract][Full Text] [Related]
34. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Castro-Rodriguez JA; Daszenies C; Garcia M; Meyer R; Gonzales R Pediatr Pulmonol; 2006 Oct; 41(10):947-53. PubMed ID: 16871594 [TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical characteristics of adenovirus and non-adenovirus pneumonia in children. Farng KT; Wu KG; Lee YS; Lin YH; Hwang BT J Microbiol Immunol Infect; 2002 Mar; 35(1):37-41. PubMed ID: 11950118 [TBL] [Abstract][Full Text] [Related]
36. TGFβ1 and POSTN as biomarkers of postinfectious bronchiolitis obliterans and asthma in children. Kang MJ; Ahn HS; Lee SY; Yeom J; Kim K; Hong SJ Pediatr Pulmonol; 2022 Dec; 57(12):3161-3164. PubMed ID: 36175004 [TBL] [Abstract][Full Text] [Related]
38. [Effect of high-titer plasma in pediatric patients with severe adenovirus pneumonia]. Peng HY; Chen FY; Dang R; Zuo YL; Hu PD; Yang YY; Zhou R; Rong X; Chen DH Zhonghua Er Ke Za Zhi; 2020 May; 58(5):392-397. PubMed ID: 32392955 [No Abstract] [Full Text] [Related]
39. Mortality reduction in pediatric patients with severe fatal human adenoviral pneumonia treated with high titer neutralizing antibodies (NAbs) plasma: a retrospective cohort study. Peng H; Chen F; Zuo Y; Huang B; Yang Y; Dang R BMC Pediatr; 2022 Mar; 22(1):151. PubMed ID: 35317780 [TBL] [Abstract][Full Text] [Related]
40. Post-infectious bronchiolitis obliterans and mannose-binding lectin insufficiency in Argentinean children. Giubergia V; Salim M; Fraga J; Castiglioni N; Sen L; Castaños C; Mangano A Respirology; 2015 Aug; 20(6):982-6. PubMed ID: 25939617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]